RTI International, a nonprofit research institute, and Nested Knowledge, a platform for AI-driven evidence synthesis, systematic literature review and meta-analysis, formally announce a strategic collaboration between the two organizations.
The Collaboration Agreement will provide clients with the opportunity to use advanced tech-enabled research services by leveraging the capabilities of the RTI Health Solutions (RTI-HS) business unit and Gen-AI tools for systematic literature reviews. RTI will also make an equity investment in Nested Knowledge.
“We’re thrilled to partner with Nested Knowledge,” said Senior Vice President Chris Simmons, head of RTI Health Solutions. “Their tools enhance scientific standards in life science and healthcare research and have already allowed our team to conduct rapid systematic literature reviews and to generate evidence-based insights for our clients.”
Also Read: Swisslog Healthcare Welcomes Brian Roberts as SVP of Medication Management, North America
Nested Knowledge provides a platform designed for creating and presenting living evidence libraries from published medical literature. Nested Knowledge is also a leading provider of AI-backed systematic and targeted literature reviews. RTI-HS has been working with Nested Knowledge’s new Gen-AI tools for its complex data extraction and design needs for literature reviews. Under the Collaboration Agreement, clients have the opportunity to benefit from enhanced analytical and technical capabilities focused on specific clinical inquiries or outcomes.
“We see RTI as a perfect partner for both using and expanding our platform’s capabilities,” said Kevin Kallmes, CEO and founder of Nested Knowledge. “We have been impressed with their rapid adoption and successful completion of reviews using our tools, specifically novel ‘living’ systematic review outputs. The combination of investment, collaborative research and co-commercialization should not only advance the field of evidence synthesis but also provide concrete, transparent, and actionable direction and demonstration of responsible use of Gen-AI.”
RTI is committed to using Gen-AI in an ethical, safe and transparent way. The institute’s investment in Nested Knowledge adds to its investment portfolio spanning domains including clinical research technology, precision medicine, healthcare analytics, patient engagement solutions, population health and diagnostic testing.
SOURCE: PRNewswire